176
Views
0
CrossRef citations to date
0
Altmetric
Original Article

Impact of the Crohn’s disease digestive damage score (Lémann Index) on the perioperative course in patients with Crohn’s disease and ileocolic anastomosis

, ORCID Icon, , , & ORCID Icon
Pages 239-246 | Received 16 Sep 2020, Accepted 20 Dec 2020, Published online: 07 Jan 2021

References

  • Hart AL, Ng SC. Crohn’s disease. Medicine. 2011;39(4):229–236.
  • Peyrin-Biroulet L, Loftus EV, Jr, Colombel JF, et al. The natural history of adult Crohn's disease in population-based cohorts. Am J Gastroenterol. 2010;105(2):289–297.
  • Domènech E, Garcia V, Iborra M, et al. Incidence and management of recurrence in patients with crohn's disease who have undergone intestinal resection: the Practicrohn study. Inflamm Bowel Dis. 2017;23(10):1840–1846.
  • Lewis RT, Maron DJ. Efficacy and complications of surgery for Crohn’s disease. Gastroenterol Hepatol (N Y). 2010;6(9):587–596.
  • Iesalnieks I, Kilger A, Glass H, et al. Intraabdominal septic complications following bowel resection for Crohn's disease: detrimental influence on long-term outcome. Int J Colorectal Dis. 2008;23(12):1167–1174.
  • Frolkis A, Kaplan GG, Patel AB, et al. Postoperative complications and emergent readmission in children and adults with inflammatory bowel disease who undergo intestinal resection: a population-based study. Inflamm Bowel Dis. 2014;20(8):1316–1323.
  • Yamamoto T, Spinelli A, Suzuki Y, et al. Risk factors for complications after ileocolonic resection for Crohn's disease with a major focus on the impact of preoperative immunosuppressive and biologic therapy: a retrospective international multicentre study. United European Gastroenterol J. 2016;4(6):784–793.
  • Tay GS, Binion DG, Eastwood D, et al. Multivariate analysis suggests improved perioperative outcome in Crohn’s disease patients receiving immunomodulator therapy after segmental resection and/or strictureplasty. Surgery. 2003;134(4):565–572.
  • Kanazawa A, Yamana T, Okamoto K, et al. Risk factors for postoperative intra-abdominal septic complications after bowel resection in patients with Crohn’s disease. Dis Colon Rectum. 2012;55:957–962.
  • Huang W, Tang Y, Nong L, et al. Risk factors for postoperative intra-abdominal septic complications after surgery in Crohn's disease: a meta-analysis of observational studies. J Crohns Colitis. 2015;9(3):293–301.
  • Morar PS, Hodgkinson JD, Thalayasingam S, et al. Determining predictors for intra-abdominal septic complications following ileocolonic resection for crohn’s disease – considerations in pre-operative and peri-operative optimisation techniques to improve outcome. J Crohns Colitis. 2015;9(6):483–491.
  • Zhu F, Li Y, Guo Z, et al. Nomogram to predict postoperative intra-abdominal septic complications after bowel resection and primary anastomosis for Crohn’s disease. Dis Colon Rectum. 2020;63:629–638.
  • Tzivanakis A, Singh JC, Guy RJ, et al. Influence of risk factors on the safety of ileocolic anastomosis in Crohn's disease surgery. Dis Colon Rectum. 2012;55(5):558–562.
  • McKenna NP, Habermann EB, Glasgow AE, et al. Intra-abdominal sepsis after ileocolic resection in Crohn’s disease: the role of combination immunosuppression. Dis Colon Rectum. 2018;61:1–1402.
  • El-Hussuna A, Andersen J, Bisgaard T, et al. Biologic treatment or immunomodulation is not associated with postoperative anastomotic complications in abdominal surgery for Crohn's disease. Scand J Gastroenterol. 2012;47(6):662–668.
  • Pariente B, Mary JY, Danese S, et al. Development of the Lémann index to assess digestive tract damage in patients with Crohn's disease. Gastroenterology. 2015;148(1):52–63.
  • Kopylov U, Eliakim R. The Lemann Index – a glance through the window of opportunity? J Crohn’s. Colitis. 2017;11:261–262.
  • Fiorino G, Bonifacio C, Allocca M, et al. Impact of therapies on bowel damage in Crohn's disease. United Eur Gastroenterol J. 2020;8(4):410–417.
  • Ribaldone DG, Caviglia GP, Pellicano R, et al. Adalimumab versus azathioprine to halt theprogression of bowel damage in Crohn’s disease: application of Lémann Index. Scand J Gastroenterol. 2019;54(11):1339–1345.
  • Bodini G, Giannini EG, De Maria C, et al. Anti-TNF therapy is able to stabilize bowel damage progression inpatients with Crohn’s disease. A study performed using the LémannIndex. Dig Liver Dis. 2017;49(2):175–180.
  • Gilletta C, Lewin M, Bourrier A, et al. Changes in the Lemann Index values during the first years of Crohn’s Disease. Clin Gastroenterol Hepatol. 2015;13(9):1633–1640.
  • Fiorino G, Bonifacio C, Allocca M, et al. Bowel damage as assessed by the Lémann Index is Reversible on Anti-TNF Therapy for Crohn's Disease. J Crohns Colitis. 2015;9(8):633–639.
  • Bhagya Rao B, Koutroubakis IE, Ramos Rivers C, et al. Delineation of Crohn’s disease trajectories using change in Lemann Index: a natural history study. J Clin Gastroenterol. 2016;50(6):476–482.
  • von Elm E, Altman DG, Egger M, STROBE Initiative, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet. 2007;370(9596):1453–1457.
  • Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Annals Surg. 2004;240(2):205–213.
  • Beddy D, Dozois EJ, Pemberton JH. Perioperative complications in inflammatory bowel disease. Inflamm Bowel Dis. 2011;17(7):1610–1619.
  • Horan TC, Gaynes RP, Martone WJ, et al. CDC definitions of nosocomial surgical site infections, 1992: a modification of CDC definitions of surgical wound infections. Am J Infect Control. 1992;20(5):271–274.
  • Liu W, Zhou W, Xiang J, et al. Lémann Index at diagnosis predicts the risk of early surgery in Crohn’s disease. Dis Colon Rectum. 2018;61:207–213.
  • Agresti A. Multiple Logistic Regression. In Agresti A. Categorial Data Analysis. 2nd ed. Hoboken: John Wiley & Sons, 2002. pp 282–285.
  • McMahon KR, Allen KD, Afzali A, et al. Predicting post-operative complications in Crohn's disease: an appraisal of clinical scoring systems and the NSQIP surgical risk calculator. J Gastrointest Surg. 2020;24(1):88–97.
  • Rentsch M, Beham A, Schlitt HJ, et al. Crohn's disease activity index and Vienna classification-is it worthwhile to calculate before surgery? Dig Surg. 2006;23(4):241–249.
  • Egberts JH, Stroeh A, Alkatout I, et al. Preoperative risk evaluation of postoperative morbidity in IBD patients – impact of the POSSUM score. Int J Colorectal Dis. 2011;26(6):783–792.
  • Zhou W, Cao Q, Qi W, et al. Prognostic Nutritional Index predicts short-term postoperative outcomes after bowel resection for Crohn’s disease. Nutr Clin Pract. 2017;32(1):92–97.
  • Zhu Y, Xu H, Liu W, et al. Glasgow prognostic score is a practical predictive index for postoperative intra-abdominal septic complications after bowel resection in Crohn’s disease patients. Int J Colorectal Dis. 2018;33(7):947–953.
  • Zuo L, Li Y, Wang H, et al. A practical predictive index for intra-abdominal septic complications after primary anastomosis for Crohn’s disease: change in C-reactive protein level before surgery. Dis Colon Rectum. 2015;58(8):775–781.
  • Patel KV, Darakhshan AA, Griffin N, et al. Patient optimization for surgery relating to Crohn's disease. Nat Rev Gastroenterol Hepatol. 2016;13(12):707–719.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.